Market LIVE
Published markets; coverage varies by country
Product profile · United States

ALLEGRA ALLERGY

 ·  Patent Litigation & Settlement History ↓

IngredientFEXOFENADINE HYDROCHLORIDE
Application typeNDA
Application020872
Product010
Dosage formTABLET
RouteORAL
Strength180MG
Approval date2011-01-24
Marketing statusOver-the-counter
Status event—
ApplicantCHATTEM SANOFI
Product source

Current GenericRadar decision

Year2011
SelectionEXCLUDED
ReviewFINAL
Anchor type—
Anchor date—
Patent anchor—
Exclusivity anchor—
Protection date—
First Final ANDA—
Status event—

Current official Orange Book exact product Type=OTC. Excluded under guideline section 4 OTC-only rule. Historical prescription status and switch effective date are not asserted.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
No patent facts are recorded for this product.

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
No exclusivity facts are recorded in this product snapshot.

2026-10-10 · NO_RECORD_IN_CURRENT_SNAPSHOT · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
076447 / 009APPLICATION_FINAL_OBSERVATION · FINAL_PRODUCT_DATE_UNVERIFIED——TEVANEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
076707 / 003APPLICATION_TENTATIVE_OBSERVATION · TENTATIVE_PRODUCT_SCOPE_UNVERIFIED——SANDOZNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
076970 / 003APPLICATION_TENTATIVE_OBSERVATION · TENTATIVE_PRODUCT_SCOPE_UNVERIFIED——RANBAXYNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
076191 / 003FINAL_APPROVAL · FINAL_APPROVED2005-08-31—BARR LABORATORIES INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
076447 / 003FINAL_APPROVAL · FINAL_APPROVED2005-09-01—TEVA PHARMACEUTICALS USA INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
076502 / 003FINAL_APPROVAL · FINAL_APPROVED2006-04-11—DR REDDYS LABORATORIES LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
077081 / 001FINAL_APPROVAL · FINAL_APPROVED2007-04-16—RISING PHARMA HOLDINGS INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
076502 / 008FINAL_APPROVAL · FINAL_APPROVED2011-04-12—DR REDDYS LABORATORIES LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
076502 / 009FINAL_APPROVAL · FINAL_APPROVED2011-04-12—DR REDDYS LABORATORIES LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
076447 / 008FINAL_APPROVAL · FINAL_APPROVED2011-04-13—TEVA PHARMACEUTICALS USA INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
077081 / 008FINAL_APPROVAL · FINAL_APPROVED2011-07-21—RISING PHARMA HOLDINGS INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
077081 / 009FINAL_APPROVAL · FINAL_APPROVED2011-07-21—RISING PHARMA HOLDINGS INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
091567 / 005FINAL_APPROVAL · FINAL_APPROVED2012-02-06—SUN PHARMACEUTICAL INDUSTRIES LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
091567 / 006FINAL_APPROVAL · FINAL_APPROVED2012-02-06—SUN PHARMACEUTICAL INDUSTRIES LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
079112 / 005FINAL_APPROVAL · FINAL_APPROVED2012-02-08—TIME CAP LABORATORIES INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
079112 / 006FINAL_APPROVAL · FINAL_APPROVED2012-02-08—TIME CAP LABORATORIES INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
202039 / 003FINAL_APPROVAL · FINAL_APPROVED2014-11-19—AUROBINDO PHARMA LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
204507 / 003FINAL_APPROVAL · FINAL_APPROVED2015-09-16—SCIEGEN PHARMACEUTICALS INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
204507 / 005FINAL_APPROVAL · FINAL_APPROVED2015-09-16—SCIEGEN PHARMACEUTICALS INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
204097 / 003FINAL_APPROVAL · FINAL_APPROVED2016-08-19—HETERO LABS LTD UNIT VNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
210137 / 001FINAL_APPROVAL · FINAL_APPROVED2018-08-13—UNIQUE PHARMACEUTICAL LABORATORIES A DIV OF JB CHEMICALS AND PHARMACEUTICALS LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
211075 / 002FINAL_APPROVAL · FINAL_APPROVED2019-10-18—GRANULES INDIA LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
212971 / 002FINAL_APPROVAL · FINAL_APPROVED2020-02-24—L PERRIGO CONEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
219032 / 002FINAL_APPROVAL · FINAL_APPROVED2025-02-28—CONTRACT PHARMACAL CORPNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
220413 / 002FINAL_APPROVAL · FINAL_APPROVED2026-07-30—DR REDDYS LABORATORIES LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 22 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
076191 / 003BARR LABORATORIES INCFINAL_APPROVAL · FINAL_APPROVED2005-08-31 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
076447 / 003TEVA PHARMACEUTICALS USA INCFINAL_APPROVAL · FINAL_APPROVED2005-09-01 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
076502 / 003DR REDDYS LABORATORIES LTDFINAL_APPROVAL · FINAL_APPROVED2006-04-11 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
077081 / 001RISING PHARMA HOLDINGS INCFINAL_APPROVAL · FINAL_APPROVED2007-04-16 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
076502 / 008DR REDDYS LABORATORIES LTDFINAL_APPROVAL · FINAL_APPROVED2011-04-12 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
076502 / 009DR REDDYS LABORATORIES LTDFINAL_APPROVAL · FINAL_APPROVED2011-04-12 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
076447 / 008TEVA PHARMACEUTICALS USA INCFINAL_APPROVAL · FINAL_APPROVED2011-04-13 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
077081 / 008RISING PHARMA HOLDINGS INCFINAL_APPROVAL · FINAL_APPROVED2011-07-21 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
077081 / 009RISING PHARMA HOLDINGS INCFINAL_APPROVAL · FINAL_APPROVED2011-07-21 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
091567 / 005SUN PHARMACEUTICAL INDUSTRIES LTDFINAL_APPROVAL · FINAL_APPROVED2012-02-06 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
091567 / 006SUN PHARMACEUTICAL INDUSTRIES LTDFINAL_APPROVAL · FINAL_APPROVED2012-02-06 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
079112 / 005TIME CAP LABORATORIES INCFINAL_APPROVAL · FINAL_APPROVED2012-02-08 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
079112 / 006TIME CAP LABORATORIES INCFINAL_APPROVAL · FINAL_APPROVED2012-02-08 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
202039 / 003AUROBINDO PHARMA LTDFINAL_APPROVAL · FINAL_APPROVED2014-11-19 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
204507 / 003SCIEGEN PHARMACEUTICALS INCFINAL_APPROVAL · FINAL_APPROVED2015-09-16 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
204507 / 005SCIEGEN PHARMACEUTICALS INCFINAL_APPROVAL · FINAL_APPROVED2015-09-16 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
204097 / 003HETERO LABS LTD UNIT VFINAL_APPROVAL · FINAL_APPROVED2016-08-19 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
210137 / 001UNIQUE PHARMACEUTICAL LABORATORIES A DIV OF JB CHEMICALS AND PHARMACEUTICALS LTDFINAL_APPROVAL · FINAL_APPROVED2018-08-13 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
211075 / 002GRANULES INDIA LTDFINAL_APPROVAL · FINAL_APPROVED2019-10-18 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
212971 / 002L PERRIGO COFINAL_APPROVAL · FINAL_APPROVED2020-02-24 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
219032 / 002CONTRACT PHARMACAL CORPFINAL_APPROVAL · FINAL_APPROVED2025-02-28 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
220413 / 002DR REDDYS LABORATORIES LTDFINAL_APPROVAL · FINAL_APPROVED2026-07-30 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
Decision evidence (1)
TypeDateRoleBasisSource
PRODUCT_STATUS—EXCLUSION_BASISExact application/product matched to current Orange Book Type=OTC; no patent or generic conclusion inferred.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.